Evidence map›Paper›PMID 38561254›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Structural white matter properties and cognitive resilience to tau pathology.

Ting Qiu, Zhen-Qi Liu, François Rheault, Jon Haitz Legarreta, Alex Valcourt Caron, Frédéric St-Onge, Cherie Strikwerda-Brown, Amelie Metz, Mahsa Dadar, Jean-Paul Soucy and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  10. Article
  11. The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyond.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Plasma biomarkers as core mediators in functional network abnormalities: Evidence from a two-cohort study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Structural white matter properties and cognitive resilience to tau pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Ting QiuDouglas Mental Health University Institute, Montreal, Canada.
Zhen-Qi LiuMontreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
François RheaultMedical Imaging and NeuroInformatics Lab, Université de Sherbrooke, Sherbrooke, Canada.
Jon Haitz LegarretaDepartment of Radiology, Brigham and Women's Hospital, Mass General Brigham/Harvard Medical School, Boston, Massachusetts, USA.
Alex Valcourt CaronSherbrooke Connectivity Imaging Laboratory, Université de Sherbrooke, Sherbrooke, Canada.
Frédéric St-OngeDouglas Mental Health University Institute, Montreal, Canada.
Cherie Strikwerda-BrownDouglas Mental Health University Institute, Montreal, Canada.
Amelie MetzDouglas Mental Health University Institute, Montreal, Canada.
Mahsa DadarDouglas Mental Health University Institute, Montreal, Canada.
Jean-Paul SoucyMontreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
Alexa Pichet BinetteClinical Memory Research Unit, Faculty of Medicine, Lund University, Lund, Sweden.
R Nathan SprengDouglas Mental Health University Institute, Montreal, Canada.
Maxime DescoteauxSherbrooke Connectivity Imaging Laboratory, Université de Sherbrooke, Sherbrooke, Canada.
Sylvia VilleneuveDouglas Mental Health University Institute, Montreal, Canada.
PREVENT‐AD Research Group
Douglas Mental Health University Institute · CAMontreal Neurological Institute and Hospital · CAUniversité de Sherbrooke · CABrigham and Women's Hospital · USLund University · SEThe University of Western Australia · AU

Funding

Alzheimer's Society Canada and Brain Canada ResearchCanadian Institutes of Health Research foundationChinese Scholarship Council 201906070287
6 · The paper itself

Abstract

introductionWe assessed whether macro- and/or micro-structural white matter properties are associated with cognitive resilience to Alzheimer's disease pathology years prior to clinical onset.

methodsWe examined whether global efficiency, an indicator of communication efficiency in brain networks, and diffusion measurements within the limbic network and default mode network moderate the association between amyloid-β/tau pathology and cognitive decline. We also investigated whether demographic and health/risk factors are associated with white matter properties.

resultsHigher global efficiency of the limbic network, as well as free-water corrected diffusion measures within the tracts of both networks, attenuated the impact of tau pathology on memory decline. Education, age, sex, white matter hyperintensities, and vascular risk factors were associated with white matter properties of both networks. DISCUSSION: White matter can influence cognitive resilience against tau pathology, and promoting education and vascular health may enhance optimal white matter properties. HIGHLIGHTS: Aβ and tau were associated with longitudinal memory change over ∼7.5 years. White matter properties attenuated the impact of tau pathology on memory change. Health/risk factors were associated with white matter properties.

Indexed as

tau ProteinsWhite MatterAgedAlzheimer DiseaseAmyloid beta-PeptidesBrainCognitionCognitive DysfunctionDiffusion Tensor ImagingFemaleHumansMaleNeuropsychological TestsRisk FactorsTauopathiesAmyloid beta-Peptidestau Proteinsamyloid‐βcognitive resiliencedefault mode networklimbic networktauwhite matter

Identifiers

PMID38561254
PMCPMC11095478
OpenAlexW4394750715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.